Literature DB >> 9030352

Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis.

H Kawamoto1, K Kawamoto, T Mizoue, T Uozumi, K Arita, K Kurisu.   

Abstract

Twenty-two pituitary adenomas were examined on the secretion of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) using a cell immunoblot assay, and discussed regarding an association between cavernous sinus invasion and the secretion of these proteins. The cell immunoblot assay, a kind of immunoblot procedure, is able to detect proteins at the single cell level and to detect the incidence of tumour cells secreting the target proteins in the total tumour cell population. The incidence of tumour cells secreting MMP-9 was significantly higher in invasive adenomas than in noninvasive ones. On the other hand, TIMP-1 secretion was not detected in any adenomas in this study. This result suggested that MMP-9 secretion, and especially the number of MMP-9-secreting cells, may be associated with cavernous sinus invasion of pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9030352     DOI: 10.1007/bf01411124

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  29 in total

Review 1.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling.

Authors:  J F Woessner
Journal:  FASEB J       Date:  1991-05       Impact factor: 5.191

Review 2.  Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model.

Authors:  J S Rao; P A Steck; P Tofilon; D Boyd; F Ali-Osman; W G Stetler-Stevenson; L A Liotta; R Sawaya
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 3.  Tumoral invasion in the central nervous system.

Authors:  Y A De Clerck; H Shimada; I Gonzalez-Gomez; C Raffel
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.

Authors:  T Nakagawa; T Kubota; M Kabuto; K Sato; H Kawano; T Hayakawa; Y Okada
Journal:  J Neurosurg       Date:  1994-07       Impact factor: 5.115

5.  Growth rate of human pituitary adenomas.

Authors:  A M Landolt; T Shibata; P Kleihues
Journal:  J Neurosurg       Date:  1987-12       Impact factor: 5.115

6.  Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta.

Authors:  C H Graham; I Connelly; J R MacDougall; R S Kerbel; W G Stetler-Stevenson; P K Lala
Journal:  Exp Cell Res       Date:  1994-09       Impact factor: 3.905

7.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

8.  Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas.

Authors:  H Kawamoto; T Uozumi; K Kawamoto; K Arita; T Yano; T Hirohata
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

9.  Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma.

Authors:  M Nakajima; D R Welch; D M Wynn; T Tsuruo; G L Nicolson
Journal:  Cancer Res       Date:  1993-12-01       Impact factor: 12.701

10.  Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion.

Authors:  H Watanabe; I Nakanishi; K Yamashita; T Hayakawa; Y Okada
Journal:  J Cell Sci       Date:  1993-04       Impact factor: 5.285

View more
  12 in total

Review 1.  Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification.

Authors:  W Saeger; S Petersenn; C Schöfl; U J Knappe; M Theodoropoulou; R Buslei; J Honegger
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

2.  Invasive pituitary adenomas: significance of proliferation parameters.

Authors:  A P Amar; D R Hinton; M D Krieger; M H Weiss
Journal:  Pituitary       Date:  1999-08       Impact factor: 4.107

3.  Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.

Authors:  Jian Gong; Yunge Zhao; Rana Abdel-Fattah; Samson Amos; Aizhen Xiao; M Beatriz S Lopes; Isa M Hussaini; Edward R Laws
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 4.  Management of aggressive pituitary adenomas and pituitary carcinomas.

Authors:  Anthony Heaney
Journal:  J Neurooncol       Date:  2014-03-02       Impact factor: 4.130

5.  The role of mediators of cell invasiveness, motility, and migration in the pathogenesis of silent corticotroph adenomas.

Authors:  Ozgur Mete; Caroline Hayhurst; Hussein Alahmadi; Eric Monsalves; Hasan Gucer; Fred Gentili; Shereen Ezzat; Sylvia L Asa; Gelareh Zadeh
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

6.  Reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase-9 are prognostic markers in skull base chordomas.

Authors:  Nunung Nur Rahmah; Keiichi Sakai; Jun Nakayama; Kazuhiro Hongo
Journal:  Neurosurg Rev       Date:  2009-10-28       Impact factor: 3.042

Review 7.  In search of a prognostic classification of endocrine pituitary tumors.

Authors:  Jacqueline Trouillas
Journal:  Endocr Pathol       Date:  2014-06       Impact factor: 3.943

8.  Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients.

Authors:  Marialaura Del Basso De Caro; Domenico Solari; Francesca Pagliuca; Alessandro Villa; Elia Guadagno; Luigi Maria Cavallo; Annamaria Colao; Guido Pettinato; Paolo Cappabianca
Journal:  Neurosurg Rev       Date:  2016-05-23       Impact factor: 3.042

9.  Does MMP-9 Gene Polymorphism Play a Role in Pituitary Adenoma Development?

Authors:  Brigita Glebauskiene; Rasa Liutkeviciene; Alvita Vilkeviciute; Loresa Kriauciuniene; Silvija Jakstiene; Egle Zlatkute; Abdonas Tamosiunas; Reda Zemaitiene; Paulina Vaitkiene; Dalia Zaliuniene
Journal:  Dis Markers       Date:  2017-01-17       Impact factor: 3.434

10.  Prenatal alcohol exposure increases the susceptibility to develop aggressive prolactinomas in the pituitary gland.

Authors:  Shaima Jabbar; Kenneth Reuhl; Dipak K Sarkar
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.